Brolucizumab-related intraocular inflammation in Japanese patients with age-related macular degeneration: a short-term multicenter study

Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2857-2859. doi: 10.1007/s00417-021-05136-w. Epub 2021 Mar 15.

Affiliations

¹ Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan. [email protected].
² Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, Japan.
³ Department of Ophthalmology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan.

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Antibodies, Monoclonal, Humanized* / adverse effects
Humans
Inflammation
Japan / epidemiology
Macular Degeneration* / diagnosis
Macular Degeneration* / drug therapy

Substances

Antibodies, Monoclonal, Humanized
brolucizumab